Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
47.80
+0.15 (0.31%)
Mar 4, 2026, 10:55 AM EST - Market open
Qiagen Employees
Qiagen had 5,967 employees as of December 31, 2023. The number of employees decreased by 211 or -3.42% compared to the previous year.
Employees
5,967
Change (1Y)
-211
Growth (1Y)
-3.42%
Revenue / Employee
$350,260
Profits / Employee
$71,205
Market Cap
9.85B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2023 | 5,967 | -211 | -3.42% |
| Dec 31, 2022 | 6,178 | 150 | 2.49% |
| Dec 31, 2021 | 6,028 | 418 | 7.45% |
| Dec 31, 2020 | 5,610 | 514 | 10.09% |
| Dec 31, 2019 | 5,096 | 144 | 2.91% |
| Dec 31, 2018 | 4,952 | 264 | 5.63% |
| Dec 31, 2017 | 4,688 | 4 | 0.09% |
| Dec 31, 2016 | 4,684 | 125 | 2.74% |
| Dec 31, 2015 | 4,559 | 220 | 5.07% |
| Dec 31, 2014 | 4,339 | 324 | 8.07% |
| Dec 31, 2013 | 4,015 | 16 | 0.40% |
| Dec 31, 2012 | 3,999 | 61 | 1.55% |
| Dec 31, 2011 | 3,938 | 351 | 9.79% |
| Dec 31, 2010 | 3,587 | 92 | 2.63% |
| Dec 31, 2009 | 3,495 | 454 | 14.93% |
| Dec 31, 2008 | 3,041 | 379 | 14.24% |
| Dec 31, 2007 | 2,662 | 708 | 36.23% |
| Dec 31, 2006 | 1,954 | 365 | 22.97% |
| Dec 31, 2005 | 1,589 | 267 | 20.20% |
| Dec 31, 2004 | 1,322 | -231 | -14.87% |
| Dec 31, 2003 | 1,553 | -98 | -5.94% |
| Dec 31, 2002 | 1,651 | 94 | 6.04% |
| Dec 31, 2001 | 1,557 | 242 | 18.40% |
| Dec 31, 2000 | 1,315 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Labcorp Holdings | 71,000 |
| Quest Diagnostics | 57,000 |
| ICON Public Limited Company | 41,900 |
| Charles River Laboratories International | 19,700 |
| Revvity | 11,000 |
| Illumina | 10,080 |
| RadNet | 9,000 |
| Exact Sciences | 7,200 |
QGEN News
- 1 day ago - Qiagen N.V. (QGEN) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 13 days ago - Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery - Business Wire
- 26 days ago - Qiagen N.V. (QGEN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 27 days ago - QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars - Business Wire
- 4 weeks ago - QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026 - Business Wire
- 5 weeks ago - Qiagen: Takeover Optionality With A High-Quality Consumables Platform - Seeking Alpha
- 5 weeks ago - QIAGEN Appoints Mark Stevenson to Supervisory Board - Business Wire
- 6 weeks ago - Qiagen Explores Possible Sale After New Buyer Talks: Report - Benzinga